Search results for "bowel"

showing 10 items of 637 documents

Accuracy of magnetic resonance enterography in the preoperative assessment of patients with Crohn's disease of the small bowel

2016

Aim to assess the accuracy of magnetic resonance-enterography in predicting the extension, location and characteristics of the small bowel segments affected by Crohn's disease. Method This is a prospective study including a consecutive series of 38 patients with small bowel Crohn's disease who underwent surgery at a specialized colorectal unit of a tertiary hospital. Preoperative magnetic resonance enterography was performed in all patients, following a homogeneous protocol, within the three months prior to surgery. A thorough exploration of the small bowel was performed during the surgical procedure, using calibration spheres, according to the discretion of the surgeon. The accuracy of mag…

AdultMalemedicine.medical_specialtyAdolescentsurgical treatmentCrohn's DiseaseConstriction Pathologic030230 surgerySensitivity and SpecificityYoung Adult03 medical and health sciences0302 clinical medicinePhlegmonCrohn Diseasesmall bowelIntestine SmallPreoperative CaremedicineHumansEndoscopy Digestive SystemProspective StudiesSurgical treatmentProspective cohort studyCrohn's diseasemagnetic resonance enterographybusiness.industryGastroenterologymedicine.diseaseMagnetic resonance enterographyequipment and suppliesMagnetic Resonance Imagingpreoperative assessmentStenosiscalibration spheresHomogeneousCalibrationFemale030211 gastroenterology & hepatologyRadiologybusinesshuman activities
researchProduct

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease

1992

A randomized, placebo-controlled multicenter trial was conducted to evaluate the efficacy and safety of a delayed-release formulation of 5-aminosalicylic acid (5-ASA) (Asacol; GiulianiBracco, Milan, Italy) for prevention of clinical relapse in 125 patients with inactive Crohn's disease. Patients in remission [Crohn's Disease Activity Index (CDAI) less than 150] between 3 months and 2 years were randomly allocated to receive either 800 mg 5-ASA three times daily (n = 64) or placebo (n = 61) for up to 12 months or until relapse of symptoms. Relapse was defined by a CDAI greater than 150, with a minimum increase of 100 points over the baseline value. The cumulative relapse rates were 12% in th…

AdultMalemedicine.medical_specialtyAminosalicylic acidAdolescentmedicine.medical_treatmentPlaceboGastroenterologychemistry.chemical_compoundCrohn DiseaseInternal medicineMulticenter trialHumansMedicineIleitisMesalamineAdverse effectAgedCrohn's diseaseHepatologybusiness.industryGastroenterologyBowel resectionMiddle AgedPrognosismedicine.diseaseConfidence intervalSurgeryAminosalicylic AcidschemistryPatient ComplianceFemalebusinessGastroenterology
researchProduct

Bowel perforation in Crohn's Disease: correlation between CDAI and Clavien-Dindo scores

2018

Background Many studies have elaborated different kind of activity indices for Crohn's Disesase (CD) with the endpoint of univocally measure and evaluate the gravity of its lesions and symptoms. Aim Purpose of this work is to study and define the correlation that runs between the preoperative score obtained at the Crohn's Disease Activity Index, the occurrence of postoperative complications that will require re-intervention and the severity of the postoperative lesions evaluated using the Clavien-Dindo score. Patients and methods We have collected and analyzed data from 23 patients (12 males, 11 females) that in a period that spans from 2010 to 2016 had been recovered in our Operative Unit …

AdultMalemedicine.medical_specialtyBowel perforationSeverity of Illness IndexClinical PracticeDisease activityCorrelation03 medical and health sciencesPostoperative Complications0302 clinical medicineCrohn DiseaseInternal medicineSeverity of illnessHumansMedicineIn patientSurgical treatmentCrohn's diseasebusiness.industrycrohnSurgical proceduresmedicine.diseaseIntestinal Perforation030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologybusinessGiornale di Chirurgia - Journal of Surgery
researchProduct

Improving Quality of Care in Inflammatory Bowel Disease Through Patients’ Eyes: IQCARO Project

2019

Abstract Background Quality improvement is a major topic in inflammatory bowel disease (IBD) care, and measuring quality of care (QoC) is necessary for QoC improvement. Most QoC projects or consensus statements are designed from the health care professional point of view. Having QoC indicators designed for and fully evaluable by patients may provide a key tool for external evaluation of QoC improvement measures. The aim of the IQCARO project was to identify indicators to measure QoC from the IBD patient’s point of view. Methods An extensive review of the literature to identify indicators of QoC was performed; first the identified indicators were reviewed by a steering committee including pa…

AdultMalemedicine.medical_specialtyConsensusQuality managementAdolescentDelphi TechniqueSteering committeeYoung Adult03 medical and health sciences0302 clinical medicineHealth caremedicineHumansImmunology and Allergy030212 general & internal medicineQuality of careQuality Indicators Health CareQuality of Health Carecomputer.programming_languagebusiness.industryGastroenterologyFocus GroupsMiddle AgedPatient Acceptance of Health CareInflammatory Bowel DiseasesQuality ImprovementFocus groupFamily medicineFemale030211 gastroenterology & hepatologyContinuity of carebusinesscomputerDelphiInflammatory Bowel Diseases
researchProduct

Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin

2009

AIM: To estimate the prevalence of small intestinal bacterial overgrowth (SIBO) in our geographical area (Western Sicily, Italy) by means of an observational study, and to gather information on the use of locally active, non-absorbable antibiotics for treatment of SIBO. METHODS: Our survey included 115 patients fulfilling the Rome II criteria for diagnosis of irritable bowel syndrome (IBS); a total of 97 patients accepted to perform a breath test with lactulose (BTLact), and those who had a positive test, received Rifaximin (Normix®, Alfa Wassermann) 1200 mg/d for 7 d; 3 wk after the end of treatment, the BTLact was repeated. RESULTS: Based on the BTLact results, SIBO was present in about 5…

AdultMalemedicine.medical_specialtyConstipationGastroenterologyRifaximinIrritable Bowel SyndromeLactulosechemistry.chemical_compoundAnti-Infective AgentsGastrointestinal AgentsInternal medicineIntestine SmallSmall intestinal bacterial overgrowthmedicineHumansSicilyIrritable bowel syndromeBreath testSettore MED/12 - GastroenterologiaGastrointestinal agentmedicine.diagnostic_testbusiness.industrydigestive oral and skin physiologyGastroenterologyBacterial InfectionsGeneral Medicinemedicine.diseaseRifamycinsLactuloseRifaximinBrief ArticlesBreath TestschemistryEtiologyFemalemedicine.symptombusinessSIBO rifaximinemedicine.drugWorld Journal of Gastroenterology
researchProduct

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study

2018

Background The addition of an immunosuppressant (IM) after loss of response to anti-TNFα monotherapy is an emerging strategy of therapeutic optimization in patients with inflammatory bowel disease (IBD). However, few clinical data have been reported to date. We aimed to evaluate the efficacy and safety of this selective combination therapy in patients with IBD. Methods All consecutive patients with loss of response to anti-TNFα monotherapy despite an intensive dose optimization who added an IM from October 2014 to October 2016 were entered into a prospective database. Results Among 630 patients treated with anti-TNFα agents during the study period, 46 (7.3%) added an IM. A total of 31 patie…

AdultMalemedicine.medical_specialtyDatabases FactualCombination therapyGastroenterologyInflammatory bowel diseaseDrug Administration Schedule03 medical and health sciences0302 clinical medicineInternal medicinemedicineAdalimumabHumansImmunology and AllergyProspective StudiesAdverse effectbiologyTumor Necrosis Factor-alphabusiness.industryRemission InductionC-reactive proteinAdalimumabGastroenterologyAntibodies MonoclonalMiddle AgedInflammatory Bowel Diseasesmedicine.diseaseInfliximabGolimumabInfliximabDiscontinuationC-Reactive ProteinTreatment Outcome030220 oncology & carcinogenesisbiology.proteinDrug Therapy CombinationFemale030211 gastroenterology & hepatologybusinessImmunosuppressive Agentsmedicine.drugInflammatory Bowel Diseases
researchProduct

Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

2017

Abstract Background Few studies investigated the role of mycophenolate mofetil in inflammatory bowel disease, and none of them had specifically focused on patients with previous multiple intolerances and/or nonresponses to conventional immunosuppressants and biologics. Aims To evaluate clinical benefit and tolerability profile of mycophenolate mofetil in patients with inflammatory bowel disease and limited treatment options. Methods All consecutive patients with previous multiple intolerances and/or nonresponses to immunosuppressants and biologics who started an off-label treatment with mycophenolate mofetil from January 2014 to February 2016 were entered in a prospectively maintained datab…

AdultMalemedicine.medical_specialtyDrug ResistanceKaplan-Meier EstimateMycophenolateInflammatory bowel diseaseGastroenterology03 medical and health sciencesYoung Adult0302 clinical medicineIntolerancesInternal medicineMedicineHumansIn patientEnzyme InhibitorsAgedCrohn's diseaseBiological ProductsHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologyMiddle AgedMycophenolic Acidmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisDiscontinuationTreatment OutcomeTolerabilityItaly030220 oncology & carcinogenesisImmunology030211 gastroenterology & hepatologyFemalebusinessImmunosuppressive AgentsDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

2020

Abstract Background and Aims Although commonly used in inflammatory bowel disease [IBD], thiopurines frequently cause intolerance, and switching to a second thiopurine has only been reported in some small series. Ours aims in this study were to evaluate the safety of switching to a second thiopurine in a large cohort, and to assess the impact of age on tolerance. Methods Adult IBD patients from the ENEIDA registry, who were switched to a second thiopurine due to adverse events [excluding malignancies and infections], were identified. At the beginning of thiopurine treatment, patients were divided by age into two groups: 18–50 and over 60 years of age. The rate and concordance of adverse eve…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsConcordanceInflammatory bowel diseaseelderly03 medical and health sciences0302 clinical medicineinflammatory bowel diseaseInternal medicineAzathioprinemedicineHumans030212 general & internal medicinePractice Patterns Physicians'Adverse effectThiopurine elderly inflammatory bowel diseaseAgedThiopurine methyltransferasebiologyThiopurinebusiness.industryDrug SubstitutionMercaptopurineGastroenterologyAge FactorsGeneral MedicineOdds ratioDrug Tolerancemedicine.diseaseInflammatory Bowel DiseasesConfidence intervaldigestive system diseasesClinical PracticeSpainbiology.proteinAcute pancreatitis030211 gastroenterology & hepatologyFemaleRisk AdjustmentDrug MonitoringbusinessImmunosuppressive Agents
researchProduct

A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Rando…

2018

Background: The reported efficacy of telemedicine in patients with inflammatory bowel disease (IBD) is inconsistent among studies, and data for complex IBD are lacking. Objective: We aimed to evaluate the impact of remote monitoring using a Web system—Telemonitorizacion de la Enfermedad de Crohn y Colitis Ulcerosa or Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU)—as compared to standard care and telephone care on health outcomes and health care in patients with complex IBD. Methods: We performed a 3-arm randomized controlled trial. Adult patients with IBD who received immunosuppressants and biological agents were recruited from the IBD Unit of a tertiary university hospita…

AdultMalemedicine.medical_specialtyHealth InformaticsPilot ProjectsInflammatory bowel diseaselaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialQuality of lifelawinflammatory bowel diseaseInternal medicineHealth caremedicineHumansAdverse effectinformation and communication technologyulcerative colitisInternetOriginal Paperbusiness.industryCrohn diseaseOdds ratioMiddle Agedmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisTelemedicineClinical trial030220 oncology & carcinogenesisQuality of Lifee-health030211 gastroenterology & hepatologyColitis UlcerativeFemaletelemedicinebusinessJournal of medical Internet research
researchProduct

Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.

2016

Recent studies documented an increased cardiovascular risk in patients with inflammatory bowel disease (IBD). Our study aimed at investigating the prevalence of intima-media thickness (IMT) of the carotid arteries and the arterial stiffness indices as markers of early atherosclerosis in young IBD patients.We recruited 68 consecutive IBD patients, and 38 matched healthy controls less than 45years old (median age 31.6±8.1years). Clinical and demographic features, cardiovascular risk factors, history of cardiovascular events, concomitant therapies were registered on a dedicate database. Carotid IMT was evaluated by using high resolution B-mode ultrasonography. Arterial stiffness was assessed b…

AdultMalemedicine.medical_specialtyIBD030204 cardiovascular system & hematologyPulse Wave AnalysisInflammatory bowel diseaseCarotid Intima-Media ThicknessCarotid intima-media thickne03 medical and health sciencesYoung Adult0302 clinical medicineVascular StiffnessCrohn DiseaseRisk FactorsInternal medicineInternal MedicinemedicineHumansMesalaminePulse wave velocityTriglyceridesSubclinical infectionCrohn's diseasebiologybusiness.industryC-reactive proteinAnti-Inflammatory Agents Non-SteroidalCholesterol HDLCholesterol LDLmedicine.diseaseAtherosclerosisInflammatory Bowel DiseasesArterial stiffneBlood pressureCarotid ArteriesCholesterolIntima-media thicknessCase-Control StudiesImmunologyEarly atherosclerosiArterial stiffnessCardiologybiology.protein030211 gastroenterology & hepatologyColitis UlcerativeFemalebusinessBiomarkersEuropean journal of internal medicine
researchProduct